Scynexis (SCYX) Goodwill & Intangibles (2020 - 2023)
Scynexis' (SCYX) quarterly Goodwill & Intangibles came in at $103000.0 in Q3 2023, down 86.62% on a YoY basis from $770000.0 in Q3 2022, and down 50.0% quarter-over-quarter from $206000.0 in Q2 2023.
Analysis
Scynexis (SCYX) Goodwill & Intangibles (2020 - 2023) Analysis & Trends
Scynexis (SCYX) has reported Goodwill & Intangibles for 4 consecutive years, with $103000.0 the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Goodwill & Intangibles fell 86.62% year-over-year to $103000.0; the trailing twelve-month figure through Sep 2023 stood at $103000.0 (down 86.62% YoY), and the FY2022 full-year result was $408000.0, down 61.36% from the prior year.
- Goodwill & Intangibles fell to $103000.0 in Q3 2023 per SCYX's latest filing, from $206000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $1.3 million in Q4 2020 and bottomed at $103000.0 in Q3 2023.
- Historically, Goodwill & Intangibles has averaged $671333.3 across 4 years, with a median of $671000.0 in 2021.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles jumped 154.23% in 2022, then tumbled 86.62% in 2023.
- Over 4 years, Goodwill & Intangibles stood at $1.3 million in 2020, then decreased by 17.63% to $1.1 million in 2021, then sank by 61.36% to $408000.0 in 2022, then sank by 74.75% to $103000.0 in 2023.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $103000.0, $206000.0, and $309000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 309,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 770,000.00 |
| Jun 30, 2022 | 866,000.00 |
| Mar 31, 2022 | 961,000.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 572,000.00 |
| Mar 31, 2021 | 378,000.00 |
| Dec 31, 2020 | 1.28 Mn |